Literature DB >> 18460069

Experimental respiratory anthrax infection in the common marmoset (Callithrix jacchus).

Mark S Lever1, Anthony J Stagg, Michelle Nelson, Peter Pearce, Daniel J Stevens, Elizabeth A M Scott, Andrew J H Simpson, Mark J Fulop.   

Abstract

Inhalational anthrax is a rare but potentially fatal infection in man. The common marmoset (Callithrix jacchus) was evaluated as a small non-human primate (NHP) model of inhalational anthrax infection, as an alternative to larger NHP species. The marmoset was found to be susceptible to inhalational exposure to Bacillus anthracis Ames strain. The pathophysiology of infection following inhalational exposure was similar to that previously reported in the rhesus and cynomolgus macaque and humans. The calculated LD(50) for B. anthracis Ames strain in the marmoset was 1.47 x 10(3) colony-forming units, compared with a published LD(50) of 5.5 x 10(4) spores in the rhesus macaque and 4.13 x 10(3) spores in the cynomolgus macaque. This suggests that the common marmoset is an appropriate alternative NHP and will be used for the evaluation of medical countermeasures against respiratory anthrax infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18460069      PMCID: PMC2525775          DOI: 10.1111/j.1365-2613.2008.00581.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  35 in total

1.  Human inhalation anthrax. A report of three fatal cases.

Authors:  W S ALBRINK; S M BROOKS; R E BIRON; M KOPEL
Journal:  Am J Pathol       Date:  1960-04       Impact factor: 4.307

2.  Studies on respiratory infection. I. The influence of particle size on respiratory infection with anthrax spores.

Authors:  H A DRUETT; D W HENDERSON; L PACKMAN; S PEACOCK
Journal:  J Hyg (Lond)       Date:  1953-09

3.  Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax.

Authors:  E D Williamson; I Hodgson; N J Walker; A W Topping; M G Duchars; J M Mott; J Estep; C Lebutt; H C Flick-Smith; H E Jones; H Li; C P Quinn
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Anthrax vaccine efficacy in golden Syrian hamsters.

Authors:  P F Fellows; M K Linscott; S F Little; P Gibbs; B E Ivins
Journal:  Vaccine       Date:  2002-01-31       Impact factor: 3.641

5.  Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.

Authors:  S F Little; G B Knudson
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

6.  Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity.

Authors:  P C Turnbull; M G Broster; J A Carman; R J Manchee; J Melling
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

7.  Multiple vaccine and pyridostigmine bromide interactions in the common marmoset Callithrix jacchus: immunological and endocrinological effects.

Authors:  Rebecca J Hornby; Peter C Pearce; Andrew P Bowditch; Leah Scott; Gareth D Griffiths
Journal:  Int Immunopharmacol       Date:  2006-08-23       Impact factor: 4.932

8.  Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers.

Authors:  B W McBride; A Mogg; J L Telfer; M S Lever; J Miller; P C Turnbull; L Baillie
Journal:  Vaccine       Date:  1998-05       Impact factor: 3.641

9.  Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques.

Authors:  B E Ivins; M L Pitt; P F Fellows; J W Farchaus; G E Benner; D M Waag; S F Little; G W Anderson; P H Gibbs; A M Friedlander
Journal:  Vaccine       Date:  1998-07       Impact factor: 3.641

10.  Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity.

Authors:  P C Turnbull; S H Leppla; M G Broster; C P Quinn; J Melling
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

View more
  20 in total

1.  Bioavailability and efficacy of levofloxacin against Francisella tularensis in the common marmoset (Callithrix jacchus).

Authors:  Michelle Nelson; Mark S Lever; Rachel E Dean; Peter C Pearce; Daniel J Stevens; Andrew J H Simpson
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

2.  Noninvasive imaging technologies reveal edema toxin as a key virulence factor in anthrax.

Authors:  Fabien Dumetz; Grégory Jouvion; Huot Khun; Ian Justin Glomski; Jean-Philippe Corre; Clémence Rougeaux; Wei-Jen Tang; Michèle Mock; Michel Huerre; Pierre Louis Goossens
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

3.  Development of an acute model of inhalational melioidosis in the common marmoset (Callithrix jacchus).

Authors:  Michelle Nelson; Rachel E Dean; Francisco J Salguero; Christopher Taylor; Peter C Pearce; Andrew J H Simpson; Mark S Lever
Journal:  Int J Exp Pathol       Date:  2011-12       Impact factor: 1.925

4.  Comparative genome analysis of the major histocompatibility complex (MHC) class I B/C segments in primates elucidated by genomic sequencing in common marmoset (Callithrix jacchus).

Authors:  Takashi Shiina; Azumi Kono; Nico Westphal; Shingo Suzuki; Kazuyoshi Hosomichi; Yuki F Kita; Christian Roos; Hidetoshi Inoko; Lutz Walter
Journal:  Immunogenetics       Date:  2011-04-20       Impact factor: 2.846

5.  Modeling Rabbit Responses to Single and Multiple Aerosol Exposures of Bacillus anthracis Spores.

Authors:  Margaret E Coleman; Harry M Marks; Timothy A Bartrand; Darrell W Donahue; Stephanie A Hines; Jason E Comer; Sarah C Taft
Journal:  Risk Anal       Date:  2017-01-25       Impact factor: 4.000

6.  Identification of a surrogate marker for infection in the African green monkey model of inhalation anthrax.

Authors:  Cynthia A Rossi; Melanie Ulrich; Sarah Norris; Douglas S Reed; Louise M Pitt; Elizabeth K Leffel
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

7.  A novel highly reproducible and lethal nonhuman primate model for orthopox virus infection.

Authors:  Marit Kramski; Kerstin Mätz-Rensing; Christiane Stahl-Hennig; Franz-Josef Kaup; Andreas Nitsche; Georg Pauli; Heinz Ellerbrok
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

8.  Differential virulence and disease progression following Mycobacterium tuberculosis complex infection of the common marmoset (Callithrix jacchus).

Authors:  Laura E Via; Danielle M Weiner; Daniel Schimel; Philana Ling Lin; Emmanuel Dayao; Sarah L Tankersley; Ying Cai; M Teresa Coleman; Jaime Tomko; Praveen Paripati; Marlene Orandle; Robin J Kastenmayer; Michael Tartakovsky; Alexander Rosenthal; Damien Portevin; Seok Yong Eum; Saher Lahouar; Sebastien Gagneux; Douglas B Young; Joanne L Flynn; Clifton E Barry
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

9.  Experimental respiratory Marburg virus haemorrhagic fever infection in the common marmoset (Callithrix jacchus).

Authors:  Sophie J Smither; Michelle Nelson; Lin Eastaugh; Thomas R Laws; Christopher Taylor; Simon A Smith; Francisco J Salguero; Mark S Lever
Journal:  Int J Exp Pathol       Date:  2013-02-27       Impact factor: 1.925

10.  Pathology and pathophysiology of inhalational anthrax in a guinea pig model.

Authors:  Vladimir Savransky; Daniel C Sanford; Emily Syar; Jamie L Austin; Kevin P Tordoff; Michael S Anderson; Gregory V Stark; Roy E Barnewall; Crystal M Briscoe; Laurence Lemiale-Biérinx; Sukjoon Park; Boris Ionin; Mario H Skiadopoulos
Journal:  Infect Immun       Date:  2013-01-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.